Increased apoptosis activity was observed in the NUCB2 knockdown group but not in the overexpression group after TMZ treatment in both GBM8401 and U87-MG cells, suggesting that NUCB2 overexpression leads to TMZ resistance in GBM cells. Here, NUCB2 is linked to glioblastoma.